Total medical devices industry venture financing deals in Q3 2019 worth $1.33bn were announced in the US, according to GlobalData’s deals database.
The value marked a decrease of 37.2% over the previous quarter and a drop of 23.5% when compared with the last four-quarter average of $1.74bn.
The US held a 58.9% share of the global medical devices industry venture financing deal value that totaled $2.26bn in Q3 2019.
In terms of deal activity, the US recorded 168 deals during Q3 2019, marking a drop of 15.6% over the previous quarter and a rise of 0.6% over the last four-quarter average.